Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: cad major surgical or invasive procedure: cabg x 2 history of present illness: 71 y.o male with known coronary artery desease past medical history: pmh: cad, htn social history: neg smoker neg alcohol family history: n/c physical exam: a/o nad supple farom neg lymphandopathy cta rrr abd - benign palp distal pulses sternum c/d/i pertinent results: 07:30am blood wbc-10.1 rbc-3.43* hgb-10.5* hct-30.0* mcv-88 mch-30.5 mchc-34.9 rdw-13.4 plt ct-159 12:08pm blood pt-12.5 ptt-29.5 inr(pt)-1.1 07:30am blood mg-2.3 chest (pa & lat) 12:09 pm pa and lateral views of the chest, three radiographs cardiac size is top normal. patient is post median sternotomy and cabg. there is minimal anterior pneumomediastinum. there is no pneumothorax. right pleural effusion is small. aside from linear atelectasis in the right base, the lungs are clear. the aorta is elongated. brief hospital course: pt admitted elective cabg surgery cabg x 2 with no complications pod o extubated in the cvicu / required no pressure suppor pod 1 stable / foley removed mn pod 2 ct removed / cxr no pneumo pod 3 wires removed pt clears for home medications on admission: atenolol 25', asa 325', norvasc 5' discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 1 months. disp:*60 capsule(s)* refills:*0* 3. furosemide 20 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 4 days. disp:*8 tablet(s)* refills:*0* 4. atorvastatin 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 5. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 6. potassium chloride 10 meq capsule, sustained release sig: two (2) capsule, sustained release po q12h (every 12 hours) for 4 days. disp:*16 capsule, sustained release(s)* refills:*0* 7. hydromorphone 2 mg tablet sig: one (1) tablet po q3h (every 3 hours) as needed for 10 days: prn for pain. disp:*40 tablet(s)* refills:*0* 8. bisacodyl 10 mg suppository sig: one (1) suppository rectal daily (daily) as needed for constipation: prn. disp:*30 suppository(s)* refills:*0* 9. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: homecare discharge diagnosis: cad htn discharge condition: good discharge instructions: 1) monitor wounds for signs of infection. these include redness, drainage or increased pain. in the event that you have drainage from your sternal wound, please contact the at (. 2) report any fever greater then 100.5. 3) report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week. 4) no lotions, creams or powders to incision until it has healed. you may shower and wash incision. please shower daily. no bathing or swimming for 1 month. use sunscreen on incision if exposed to sun. 5) no lifting greater then 10 pounds for 10 weeks. 6) no driving for 1 month. 7) call with any questions or concerns. followup instructions: provider: , . follow-up appointment should be in 1 month provider: , follow-up appointment should be in 2 weeks procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of one coronary artery diagnoses: coronary atherosclerosis of native coronary artery unspecified essential hypertension 

Answer: The patient is high likely exposed to